How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patientʼs perspective

Authors

Keywords

Journal

Volume 32, Issue 3, Pages 395-404

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2019-04-15

DOI

10.1097/wco.0000000000000689

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now